Diagnostics involves investigating and discovering certain diseases, conditions and injuries by closely studying various symptoms and indications displayed by patients. In broad terms, today’s Diagnostics Industry breaks down into the following categories, namely in-vitro diagnostics (IVD) (examination of diverse tissue samples in a laboratory) and in-vivo diagnostics (observation and testing of tissue and any organ’s functioning by exploiting the techniques like medical (diagnostic) imaging and monitoring).
A nearly EUR 37.5 billion sector, in-vitro diagnostics promises enormous growth potential, with governments increasingly redefining soaring healthcare spending and starting to pour investments into the high tech diagnostics business. The latter continues to be superintended by a mere scattering of behemoths. Major forces fuelling the industry development include, among others, innovative approaches regarding equipment and clinical trial activities.
This Catalogue presents an invaluable collection of research reports examining the Diagnostics and Diseases Market worldwide, by various regions and selected countries. The research reports feature market sizing analyses and growth rate reviews, discussions of factors diving or deterring the growth of the Diagnostics and Diseases Industry, information on market dynamics and share, etc. The profiles of large-to-micro caps, and the Diagnostics and Diseases Market forecasts are provided in the research reports too.
Publications found:
43,318
Sort by:
World Market for Cancer Therapeutics and Biotherapeutics, 4th Edition, The
US$ 3,500.00
... Kalorama Information report - The World Market for Cancer Therapeutics and Biotherapeutics, 4th Edition - focuses on several segments for cancer treatment including: ... complete research effort into the oncology treatments market in the past ten years, provides market size information for the various types of ...
October 2011
245 pages
The US AIDS Diagnostics Market: Test Volumes, Sales Forecasts, and Supplier Shares
US$ 1,480.00
Summary This report presents a detailed analysis of the US AIDS diagnostics market, including test volume and sales forecasts for HIV-1/2, HIV ... , Western Blot and other confirmatory tests performed in the following market segments: Hospitals Commercial/Private Laboratories Blood Banks Physician Offices ...
October 2011
251 pages
French AIDS Diagnostic Market: Test Volumes, Sales Forecasts, and Supplier Shares
US$ 1,000.00
Summary This report presents a detailed analysis of the French AIDS diagnostics market, including test volume and sales forecasts for HIV-1/2, ... /Private Laboratories Blood Banks Physician Offices Public Health Laboratories In addition to test volume and sales projections, the report presents sales and ...
October 2011
251 pages
Cancer Therapies: Market Research Report
US$ 4,500.00
... report analyzes the worldwide markets for Cancer Therapies in US$ Million by the following Product Segments: Immunotherapy, Targeted Therapy, Hormonal Therapy, and Chemotherapy. ... 2017. A six-year historic analysis is also provided for these markets. The report profiles 152 companies including many key and ...
October 2011
897 pages
Emerging Infectious Disease Testing Technologies and Market Applications
US$ 760.00
This report provides a detailed analysis of the current and emerging technologies, and their potential applications for the infectious disease testing market, including DNA probes, biochips, monoclonal antibodies, immunoassays, IT, gel microdroplets, differential light scaltering, chromatography and several ...
September 2011
61 pages
U.S. Market for In-Vitro Diagnostics 2011 (immunochemistry, molecular diagnostics, blood donor screening, hemostasis, hematology and point-of-care testing)
US$ 7,495.00
... Testing Urinalysis Testing Blood Glucose Testing In 2010, the U.S. in vitro diagnostics market experienced significant growth due to the introduction of new Food ... , companies such as Siemens, Roche Diagnostics, Abbott Diagnostics and Beckman Coulter lead the market, among many others. This report provides ...
September 2011
322 pages
Global Infectious Disease Drug Market: Strategic Assessments of Leading Suppliers
US$ 7,840.00
... product segments: ethical, OTC, generics. Sales forecast for major drug categories. Sales forecasts by geographical region: North America, Europe, Japan ... , goals and strategies of the leading players in the global infectious disease drug market. To help current suppliers realistically assess their financial ...
September 2011
1353 pages
Turn of The Decade: Novel Glp-1’s To Emerge as the New Leader in Diabetes Class
US$ 2,000.00
Turn of The Decade: Novel Glp-1’s To Emerge as the New Leader in Diabetes Class Bydureon – A near term growth driver of the class Novel delivery platforms and fixed ... in cumulative peak sales for this class of drugs by the turn of this decade as we see innovation efforts around this class will result in ...
September 2011
68 pages
Cell Surface Markers: US, Europe, Japan Forecasts by Test, Market Segment and Country
US$ 3,560.00
... are capable of making antibody against a particular antigen, and to sort those cells into separate culture vessels. This permits the screening and ... five years, the main trend in flow cytometry in general, and in cell surface marker analysis specifically, will be further simplification of the sample preparation ...
August 2011
120 pages
NAT Applications For Forensic, Paternity and Disease Susceptibility Testing
US$ 680.00
Global PDF: US$ 1,900.00 The report presents: Overview of the clinical significance and market needs for major forensic, paternity, disease susceptibility and other NAT applications. Extensive listings of companies developing and marketing NAT technologies and products. Contains 32 pages
August 2011
32 pages
Incontinence in Tunisia
US$ 900.00
... production and distribution plants within the country. Euromonitor International's Incontinence in Tunisia report offers a comprehensive guide to the size and shape ... data. Why buy this report? Get a detailed picture of the Incontinence market; Pinpoint growth sectors and identify factors driving change ...
August 2011
13 pages
Companion Diagnostics: World Market Outlook 2011-2021
US$ 2,325.00
... both primary and secondary. This report provides detailed sales forecasts, market share analyses, discussions of pipeline developments and analyses of commercial drivers ... opinion to benefit your work. Why you should buy Companion Diagnostics: World Market Outlook 2011-2021 In this report, you will receive ...
August 2011
108 pages
Global Hepatitis C Virus (HCV) Market - An Analysis
US$ 800.00
... come due to increase in number of HCV positive drug addicts. This report titled “Global Hepatitis C Virus (HCV) Market– An Analysis” analyzes the various ... types, stages and incidences of HCV in different geographies. ...
August 2011
47 pages
Competitor Analysis: Targeted Therapy of Hepatitis C
US$ 826.00
Product description The present Competitive Intelligence Report about Targeted Therapy of Hepatitis C provides a competitor evaluation in the field of specifically targeted antiviral therapeutics for hepatitis C (STAT-C) as of August 2011. Purchase of the downloadable pdf report includes a 6-month online ...
August 2011
91 pages
China Diabetes Market Analysis
US$ 800.00
Single User PDF Format: US$ 800.00
Multi-User License: US$ 1,200.00
Hard Copy: US$ 900.00
CD-ROM: US$ 900.00 Diabetes has emerged as one of the most common diseases in China, affecting...
July 2011
50 pages
Global Cord Blood Banking Market: Focus on China
US$ 700.00
... about cord blood banking. Key issues like entry barriers in cord blood banking, collection and storage problem have been discussed. The competition prevailing in the global cord blood banking market has ...
July 2011
35 pages
Indian Diagnostic Market Analysis
US$ 800.00
Single User PDF Format: US$ 800.00 Multi-User License: US$ 1400.00 Hard Copy: US$ 1000.00 CD-ROM: US$ 1000.00Indian diagnostics sector is witnessing an era of immense progress in innovative competenc...
June 2011
65 pages
Molecular Diagnostics Market Report: 2011 Edition
US$ 800.00
... , QIAGEN, Bayer, Abbott, and Becton Dickinson. The current report analyzes the molecular diagnostic market on the global basis. It also presents a view of the various ...
June 2011
43 pages
Looking at the Cancer Therapy Market
US$ 200.00
... presents a comprehensive research report – Looking at the Cancer Therapy Market – which analyzes the global cancer market. Explaining the basics of cancer, to the treatments available and ...
June 2011
60 pages
Umbilical Cord Blood Banking Market Trends 2011
US$ 1,323.00
... , utilization trends of cord blood for different diseases in different countries of the world. This report analyzes the umbilical cord blood marketplace ... and associated qualitative trends. This data-driven characterization of the cord blood banking market landscape is a hands-on document that can be used for ...
May 2011
42 pages
US Oncologist Survey: Optimizing Treatment for Advanced Lung Cancer
US$ 1,200.00
... to 154 oncologists in a survey for their open-ended responses providing rich insight into their clinical decisions. Data includes specific treatment ... with adenocarcinoma Former light smoker whose cancer is EGFR positive Treatment decisions for advanced stages of cancer are difficult to track as information ...
April 2011
56 pages
The Blood Banking Market
US$ 22,880.00
... Global PDF: US$ 62,900.00 About This Report The “Blood Banking Market” report is part of a multiclient study series published by VENTURE PLANNING GROUP ... segmentation analysis, including review of the market dynamics, trends, structure, size, growth, and key suppliers, by country. Test volume and sales ...
April 2011
850 pages
Japan Diabetes Market Report & Forecast 2011-2016
US$ 750.00
IMARC’s new report “Japan Diabetes Market Report & Forecast 2011-2016” provides an analytical and statistical insight into the Japanese diabetes market. The report provides both current and future tre...
April 2011
37 pages
Competitor Analysis: Targeted Therapy of Diabetes
US$ 1,735.00
Product description The present Competitive Intelligence Report about Targeted Therapy of Diabetes provides a competitor evaluation in the field of novel molecules being developed for treatment of type 1 and 2 diabetes as of April 2011. Major pharmacologic approaches include insulin, PPAR agonists, DPP-IV ...
April 2011
114 pages
Castration Resistant Prostate Cancer: Clinical Insights from a US Oncologists' Survey
US$ 500.00
... for their open-ended responses providing rich insight into their clinical decisions. Data includes specific treatment and testing choices, factors ... are missing, directly from high-prescribing US oncologists on the treatment of patients with advanced prostate cancer. Treatment decisions for advanced stages ...
March 2011
24 pages
US Oncologist Survey: Optimizing Treatment for Advanced Prostate Cancer
US$ 1,200.00
... that unfold throughout the report, presented to 119 high-prescribing oncologists on Metastatic Clear Cell Renal Cell Cancer for their open ... , barriers to optimal care, and confidence in treatment. Patients include: Patient case scenarios that progressively unfold, presented to 154 oncologists in a survey for ...
March 2011
52 pages
Diabetes Market in UAE
US$ 800.00
Single User PDF Format: US$ 800.00
Multi-User License: US$ 1,200.00
Hard Copy: US$ 900.00
CD-ROM: US$ 900.00 Diabetes is the world’s most costly epidemic. It is anticipated that, over...
February 2011
35 pages
Competitor Analysis: Cancer Antibodies in Early Clinical Development
US$ 1,210.00
... CD20, VEGF and Her2, but also of many new and unique antibodies directed against novel targets which will have to show its ... cancer. In addition, the report lists company-specific R&D pipelines of anti-cancer antibodies. Competitor projects are listed in a tabular format providing information on: Drug Codes, ...
February 2011
183 pages
Oncologist Survey: Optimizing Treatment for Advanced Renal Cell Cancer
US$ 500.00
Treatment decisions for advanced stages of renal cell cancer are difficult to track as information quickly changes along with the introduction of new products that all have an impact oncologists’ choices. This series of reports will allow you to see what is actually happening ...
February 2011
59 pages
US Oncologist Survey: Optimizing Treatment for Metastatic Breast Cancer
US$ 1,200.00
Treatment decisions for advanced stages of breast cancer are difficult to track as information quickly changes along with the introduction of new products that all have an impact oncologists’ choices. This series of reports will allow you to see what is actually happening at ...
January 2011
59 pages
